The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo

J Antibiot (Tokyo). 2017 Aug;70(9):937-943. doi: 10.1038/ja.2017.64. Epub 2017 Jun 7.

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that can be very hard to treat because of high resistance to different antibiotics and alternative treatment regimens are greatly needed. An alternative or a complement to traditional antibiotic is to inhibit virulence of the bacteria. The salicylidene acylhydrazide, INP0341, belongs to a class of compounds that has previously been shown to inhibit virulence in a number of Gram-negative bacteria. In this study, the virulence blocking effect of INP0341 on P. aeruginosa was studied in vitro and in vivo. Two important and closely related virulence system were examined, the type III secretion system (T3SS) that translocates virulence effectors into the cytosol of the host cell to evade immune defense and facilitate colonization and the flagella system, needed for motility and biofilm formation. INP0341 was shown to inhibit expression and secretion of the T3SS toxin exoenzyme S (ExoS) and to prevent bacterial motility on agar plates and biofilm formation. In addition, INP0341 showed an increased survival of P. aeruginosa-infected mice. In conclusion, INP0341 attenuates P. aeruginosa virulence.

MeSH terms

  • ADP Ribose Transferases / antagonists & inhibitors
  • ADP Ribose Transferases / metabolism
  • Administration, Cutaneous
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Physiological Phenomena / drug effects
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Bacterial Toxins / antagonists & inhibitors
  • Bacterial Toxins / metabolism
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Burns / complications
  • Burns / microbiology
  • Drug Resistance, Multiple, Bacterial
  • Flagella / drug effects*
  • Flagella / physiology
  • HeLa Cells
  • Humans
  • Hydrazines / administration & dosage
  • Hydrazines / adverse effects
  • Hydrazines / pharmacology
  • Hydrazines / therapeutic use*
  • Male
  • Mice, Inbred BALB C
  • Mutation
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / metabolism
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / growth & development
  • Pseudomonas aeruginosa / pathogenicity
  • Pseudomonas aeruginosa / physiology
  • Sigma Factor / genetics
  • Sigma Factor / metabolism
  • Survival Analysis
  • Trans-Activators / genetics
  • Trans-Activators / metabolism
  • Virulence / drug effects
  • Wound Infection / drug therapy*
  • Wound Infection / metabolism
  • Wound Infection / microbiology

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Bacterial Toxins
  • ExsA protein, Pseudomonas aeruginosa
  • FliA protein, Bacteria
  • Hydrazines
  • INP 0341
  • Sigma Factor
  • Trans-Activators
  • ADP Ribose Transferases
  • exoenzyme S